Convergence Investment Partners LLC Takes $217,000 Position in HealthEquity, Inc. (NASDAQ:HQY)

Convergence Investment Partners LLC purchased a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 2,262 shares of the company’s stock, valued at approximately $217,000.

Several other institutional investors and hedge funds have also recently modified their holdings of HQY. Louisiana State Employees Retirement System increased its holdings in HealthEquity by 0.4% during the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company’s stock valued at $2,322,000 after buying an additional 100 shares during the period. Raymond James Trust N.A. grew its holdings in HealthEquity by 4.8% in the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock worth $238,000 after purchasing an additional 132 shares during the last quarter. CIBC Asset Management Inc grew its holdings in HealthEquity by 5.6% in the fourth quarter. CIBC Asset Management Inc now owns 2,640 shares of the company’s stock worth $253,000 after purchasing an additional 139 shares during the last quarter. Sanctuary Advisors LLC grew its holdings in HealthEquity by 5.0% in the fourth quarter. Sanctuary Advisors LLC now owns 3,335 shares of the company’s stock worth $320,000 after purchasing an additional 159 shares during the last quarter. Finally, UMB Bank n.a. grew its holdings in HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after purchasing an additional 164 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

Insider Transactions at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the sale, the director now directly owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. This represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 39,000 shares of company stock valued at $3,895,788 over the last 90 days. Corporate insiders own 2.20% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have issued reports on HQY shares. Bank of America lifted their price target on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Mizuho initiated coverage on shares of HealthEquity in a report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price objective on the stock. BTIG Research boosted their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Royal Bank of Canada boosted their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday, December 10th. Finally, The Goldman Sachs Group initiated coverage on shares of HealthEquity in a report on Friday, November 15th. They set a “neutral” rating and a $108.00 price objective on the stock. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, HealthEquity presently has an average rating of “Moderate Buy” and a consensus target price of $110.71.

HealthEquity Trading Up 0.4 %

Shares of HealthEquity stock opened at $113.74 on Thursday. The firm has a 50-day simple moving average of $103.06 and a two-hundred day simple moving average of $91.63. The company has a market cap of $9.86 billion, a P/E ratio of 104.35, a price-to-earnings-growth ratio of 1.62 and a beta of 0.55. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter last year, the company posted $0.40 earnings per share. As a group, equities analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.